These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16178732)

  • 1. Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2).
    Rudd MT; McCauley JA
    Curr Top Med Chem; 2005; 5(9):869-84. PubMed ID: 16178732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders.
    Célanire S; Campo B
    Expert Opin Drug Discov; 2012 Mar; 7(3):261-80. PubMed ID: 22468956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-selective noncompetitive modulators of metabotropic glutamate receptor subtype 1 (mGluR1).
    Layton ME
    Curr Top Med Chem; 2005; 5(9):859-67. PubMed ID: 16178731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5).
    Williams DL; Lindsley CW
    Curr Top Med Chem; 2005; 5(9):825-46. PubMed ID: 16178729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors.
    Marino MJ; Conn PJ
    Curr Opin Pharmacol; 2006 Feb; 6(1):98-102. PubMed ID: 16368268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 1,5-disubstituted pyridones: a new class of positive allosteric modulators of the metabotropic glutamate 2 receptor.
    Cid JM; Duvey G; Cluzeau P; Nhem V; Macary K; Raux A; Poirier N; Muller J; Boléa C; Finn T; Poli S; Epping-Jordan M; Chamelot E; Derouet F; Girard F; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; Lavreysen H; Linares ML; Oehlrich D; Oyarzábal J; Tresadern G; Trabanco AA; Andrés JI; Le Poul E; Imogai H; Lutjens R; Rocher JP
    ACS Chem Neurosci; 2010 Dec; 1(12):788-95. PubMed ID: 22778815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia.
    Fraley ME
    Expert Opin Ther Pat; 2009 Sep; 19(9):1259-75. PubMed ID: 19552508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5.
    O'Brien JA; Lemaire W; Chen TB; Chang RS; Jacobson MA; Ha SN; Lindsley CW; Schaffhauser HJ; Sur C; Pettibone DJ; Conn PJ; Williams DL
    Mol Pharmacol; 2003 Sep; 64(3):731-40. PubMed ID: 12920211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.
    Johnson MP; Baez M; Jagdmann GE; Britton TC; Large TH; Callagaro DO; Tizzano JP; Monn JA; Schoepp DD
    J Med Chem; 2003 Jul; 46(15):3189-92. PubMed ID: 12852748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
    Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
    Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
    J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive and negative modulation of circadian activity rhythms by mGluR5 and mGluR2/3 metabotropic glutamate receptors.
    Gannon RL; Millan MJ
    Neuropharmacology; 2011; 60(2-3):209-15. PubMed ID: 20831878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of group II metabotropic glutamate receptor modulation on ethanol- and sucrose-seeking and consumption in the rat.
    Windisch KA; Czachowski CL
    Alcohol; 2018 Feb; 66():77-85. PubMed ID: 29220747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptor subtypes.
    Sekiyama N; Hayashi Y; Nakanishi S; Jane DE; Tse HW; Birse EF; Watkins JC
    Br J Pharmacol; 1996 Apr; 117(7):1493-503. PubMed ID: 8730745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel family of potent negative allosteric modulators of group II metabotropic glutamate receptors.
    Hemstapat K; Da Costa H; Nong Y; Brady AE; Luo Q; Niswender CM; Tamagnan GD; Conn PJ
    J Pharmacol Exp Ther; 2007 Jul; 322(1):254-64. PubMed ID: 17416742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia.
    Govek SP; Bonnefous C; Hutchinson JH; Kamenecka T; McQuiston J; Pracitto R; Zhao LX; Gardner MF; James JK; Daggett LP; Rowe BA; Schaffhauser H; Bristow LJ; Campbell UC; Rodriguez DE; Vernier JM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4068-72. PubMed ID: 16005222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of mGluRs shed light on the challenges of drug development of allosteric modulators.
    Bennett KA; Doré AS; Christopher JA; Weiss DR; Marshall FH
    Curr Opin Pharmacol; 2015 Feb; 20():1-7. PubMed ID: 25462286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment-Based Optimization of Dihydropyrazino-Benzimidazolones as Metabotropic Glutamate Receptor-2 Positive Allosteric Modulators against Migraine.
    Szabó G; Erdélyi P; Kolok S; Vastag M; Halász AS; Kis-Varga I; Lévay GI; Béni Z; Kóti J; Greiner I; Keserű GM
    J Med Chem; 2021 Jun; 64(12):8607-8620. PubMed ID: 34080424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterisation of the novel positive allosteric modulators of the mGlu₅ receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat.
    Gilmour G; Broad LM; Wafford KA; Britton T; Colvin EM; Fivush A; Gastambide F; Getman B; Heinz BA; McCarthy AP; Prieto L; Shanks E; Smith JW; Taboada L; Edgar DM; Tricklebank MD
    Neuropharmacology; 2013 Jan; 64():224-39. PubMed ID: 22884720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.